GO:0099011 neuronal dense core vesicle exocytosis: Secretory Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0099011 describes the calcium-triggered fusion of neuronal dense core vesicles (DCVs) with the plasma membrane, releasing neuropeptides, neuromodulators, and hormones.
• DCV exocytosis is molecularly distinct from synaptic vesicle exocytosis, requiring specific proteins such as CAPS/UNC-31 and Munc18-1.
• Key regulators include CAPS1, Munc18-1, Vti proteins, and chromogranins, which control docking, priming, and cargo composition.
• Dysregulation of DCV exocytosis is implicated in neurological and metabolic disorders, including neurodegeneration and diabetes.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of DCV exocytosis mechanisms in neurons.
• Advanced methods such as live-cell imaging, proteomics, and electrophysiology are essential to study DCV exocytosis dynamics.
Description
Neuronal dense core vesicle exocytosis (GO:0099011) is a specialized secretory process by which neurons release neuropeptides, neuromodulators, and hormones in response to elevated cytosolic calcium. Unlike synaptic vesicle exocytosis, which mediates fast neurotransmission, DCV exocytosis is slower and often occurs at extrasynaptic sites, modulating neuronal activity and plasticity. This process is critical for intercellular communication and is conserved from invertebrates to mammals. Understanding DCV exocytosis is essential for deciphering how neurons regulate complex behaviors, stress responses, and metabolic homeostasis. Defects in this pathway have been linked to neurological disorders, including neurodegeneration and neurodevelopmental conditions. Moreover, DCVs are the neuronal counterpart of endocrine secretory granules, making their study relevant to metabolic diseases such as diabetes. Researchers leverage genetic models, advanced imaging, and proteomics to uncover the molecular machinery and regulatory mechanisms of DCV exocytosis.
neuronal dense core vesicle exocytosis At A Glance
| GO ID | GO:0099011 |
|---|---|
| GO term | neuronal dense core vesicle exocytosis |
| Ontology | biological_process |
| Synonym | None |
| Major function | Calcium-dependent secretion of neuropeptides and neuromodulators from neurons |
| Cellular location | Neuronal plasma membrane and dense core vesicles |
| Key trigger | Increased cytosolic calcium levels |
| Associated proteins | CAPS1, Munc18-1, Vti proteins, chromogranins, and others |
What Is GO:0099011?
GO:0099011, neuronal dense core vesicle exocytosis, is defined as the secretion of molecules such as neuropeptides, insulin-related peptides, or neuromodulators (e.g., serotonin and dopamine) contained within a neuronal dense core vesicle by fusion of the granule with the plasma membrane of a neuron in response to increased cytosolic calcium levels.
Why Is neuronal dense core vesicle exocytosis Important in Cell Biology?
Neuronal dense core vesicle exocytosis is fundamental for neuronal communication and homeostasis, as it controls the release of neuropeptides and neuromodulators that regulate mood, pain, feeding, and stress responses. Dysregulation of this process contributes to a range of pathologies, including neurodegenerative diseases, psychiatric disorders, and metabolic syndromes. Studying DCV exocytosis provides insights into basic secretory mechanisms and offers potential therapeutic targets for conditions such as chronic pain and diabetes.
• Regulates release of neuropeptides and neuromodulators, influencing neuronal excitability and plasticity.
• Distinct from synaptic vesicle exocytosis, requiring unique molecular machinery like CAPS and Munc18-1.
• Implicated in chronic pain sensitization via neuropeptide Y regulation.
• Linked to metabolic disorders through insulin-related peptide secretion.
• Chromogranins A and B are essential for DCV biogenesis and cargo packaging.
• CAPS1 RNA editing fine-tunes DCV exocytosis efficiency.
• Vti proteins regulate DCV trafficking and fusion beyond endolysosomal functions.
• Tomosyn affects DCV composition but not exocytosis, highlighting cargo sorting complexity.
• Provides targets for therapeutic intervention in neurological and endocrine diseases.
• CRISPR screens enable discovery of novel regulators of DCV exocytosis.
What Happens During neuronal dense core vesicle exocytosis?
DCV Biogenesis and Cargo Packaging
In simple terms: Dense core vesicles are built and filled with signaling molecules inside the neuron.
Dense core vesicles (DCVs) originate from the trans-Golgi network, where cargo proteins such as chromogranins A and B are packaged along with neuropeptides and hormones. Chromogranins are critical for proper DCV biogenesis, as neurons lacking both chromogranins show altered DCV composition and reduced exocytosis. The cargo is sorted into immature granules that undergo maturation, including acidification and proteolytic processing.
DCV Trafficking and Docking
In simple terms: Vesicles move to the cell membrane and attach, waiting for a signal.
After biogenesis, DCVs are transported along microtubules to the plasma membrane. Docking is mediated by proteins such as Munc18-1, which promotes the stable attachment of DCVs to the plasma membrane. Vti proteins also play roles in DCV trafficking and docking, beyond their known functions in endolysosomal trafficking. Tomosyn, a syntaxin-binding protein, affects DCV composition but not exocytosis, indicating that docking and fusion are regulated independently.
Priming and Calcium Sensing
In simple terms: Vesicles become ready to fuse, and a calcium signal triggers the final step.
Priming involves the assembly of the SNARE complex and the binding of CAPS (UNC-31 in C. elegans), a calcium-dependent activator of secretion. CAPS1 RNA editing further modulates DCV exocytosis, suggesting a fine-tuning mechanism. Upon calcium influx, synaptotagmins and other calcium sensors trigger rapid fusion.
Fusion and Cargo Release
In simple terms: The vesicle merges with the membrane, releasing its contents outside the cell.
Calcium-triggered fusion of the DCV with the plasma membrane releases neuropeptides and neuromodulators into the extracellular space. This process requires the SNARE complex and is regulated by proteins such as Munc18-1 and CAPS. The fusion pore expands, allowing full cargo release, which can modulate neuronal activity and behavior.
Regulation by Neuropeptides and Modulators
In simple terms: The released molecules can feedback to control further release.
Neuropeptide Y (NPY) regulates DCV exocytosis from dorsal root ganglion neurons, acting as an autocrine or paracrine modulator. This feedback regulation fine-tunes secretion according to neuronal activity and physiological demand. Additionally, CAPS1 RNA editing can alter the efficiency of DCV exocytosis, providing another layer of control.
Key Genes Involved in GO:0099011 neuronal dense core vesicle exocytosis
The following genes and proteins are central to neuronal dense core vesicle exocytosis, as identified in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAPS1 (CADPS) | Calcium-dependent activator of secretion; essential for DCV exocytosis | RNA editing regulates DCV exocytosis; knockout impairs release |
| UNC-31 (C. elegans CAPS) | Required for DCV but not synaptic vesicle exocytosis | Genetic model for DCV-specific secretion |
| Munc18-1 (STXBP1) | Promotes DCV docking | Knockout reduces docking; key for secretion |
| Chromogranin A (CHGA) | DCV biogenesis and cargo packaging | Double knockout alters DCV composition and exocytosis |
| Chromogranin B (CHGB) | DCV biogenesis and cargo packaging | Double knockout alters DCV composition and exocytosis |
| Vti1a (VTI1A) | DCV trafficking and fusion | Regulates DCV exocytosis beyond endolysosomal roles |
| Vti1b (VTI1B) | DCV trafficking and fusion | Regulates DCV exocytosis beyond endolysosomal roles |
| Tomosyn (STXBP5) | Affects DCV composition | Knockout changes cargo but not exocytosis |
| Neuropeptide Y (NPY) | Regulates DCV exocytosis | Modulates release from DRG neurons |
| Synaptotagmin I (SYT1) | Calcium sensor for fusion | General secretory role; not DCV-specific |
| Syntaxin-1A (STX1A) | SNARE complex component | Essential for fusion; interacts with Munc18-1 |
| SNAP-25 (SNAP25) | SNARE complex component | Essential for fusion |
| VAMP2 (VAMP2) | SNARE complex component | Essential for fusion |
| Rab3A (RAB3A) | Vesicle trafficking and docking | Regulates DCV exocytosis |
| Rab27A (RAB27A) | Vesicle trafficking and docking | Regulates DCV exocytosis |
| Calcium channels (e.g., CACNA1A) | Calcium influx triggers exocytosis | Essential for calcium-dependent release |
| Serotonin (5-HT) | Cargo of DCVs | Neuromodulator released via DCV exocytosis |
| Dopamine (DA) | Cargo of DCVs | Neuromodulator released via DCV exocytosis |
How Is neuronal dense core vesicle exocytosis Regulated?
Neuronal dense core vesicle exocytosis is regulated at multiple levels. Calcium influx through voltage-gated calcium channels is the primary trigger. CAPS1 RNA editing modulates the efficiency of DCV exocytosis, providing a post-transcriptional regulatory mechanism. Neuropeptide Y acts as a negative feedback regulator of DCV exocytosis in dorsal root ganglion neurons. Additionally, tomosyn affects DCV composition without altering exocytosis, suggesting that cargo sorting and fusion are independently regulated. Chromogranins A and B are required for proper DCV biogenesis and cargo packaging, indirectly influencing exocytosis.
neuronal dense core vesicle exocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STXBP1 (Munc18-1) | Epileptic encephalopathy | Knockout or point mutation in neurons |
| CHGA | Neuroendocrine tumors, neurodegeneration | Knockout in neuroendocrine cells |
| NPY | Chronic pain | Overexpression or knockout in DRG neurons |
| CADPS (CAPS1) | Neurodevelopmental disorders | RNA editing knockout or knock-in |
| VTI1A | Neurodegeneration | Knockout in neurons |
Neurodegenerative Diseases
Defects in DCV exocytosis have been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where altered neuropeptide release contributes to neuronal dysfunction. Chromogranin A, a major DCV cargo protein, is a biomarker for neuroendocrine tumors and is linked to neurodegeneration.
Chronic Pain
Neuropeptide Y regulates DCV exocytosis from dorsal root ganglion neurons, and dysregulation of this pathway is associated with chronic pain sensitization. Targeting DCV exocytosis in sensory neurons may offer therapeutic avenues for pain management.
Metabolic Disorders
DCVs in neurons share machinery with endocrine secretory granules, and impaired exocytosis can lead to metabolic disorders such as diabetes. Insulin-related peptides are released via DCV exocytosis, linking this process to glucose homeostasis.
Neurodevelopmental Disorders
Mutations in Munc18-1 (STXBP1) cause early infantile epileptic encephalopathy, highlighting the importance of DCV exocytosis in brain development. CAPS1 RNA editing defects may also contribute to neurodevelopmental phenotypes.
From neuronal dense core vesicle exocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate DCV exocytosis? | Knockout cell model (e.g., CRISPR KO in neurons) |
| Does a point mutation in gene X affect DCV exocytosis? | Point mutation knock-in cell model |
| Does tagging gene X affect its localization? | Tagged knock-in cell model |
| Does overexpression of gene X enhance DCV exocytosis? | Overexpression cell model |
| Which genes are essential for DCV exocytosis? | CRISPR library screening |
| How does gene X mutation affect neuronal function? | Knock-in mouse model |
How to Study the neuronal dense core vesicle exocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Vesicle trafficking, docking, fusion | Real-time DCV exocytosis dynamics |
| Electrophysiology | Calcium currents, membrane capacitance | Quantifying fusion events |
| Proteomics | DCV cargo composition | Identifying cargo changes in mutants |
| CRISPR screens | Gene essentiality for DCV exocytosis | Discovery of novel regulators |
| RNA editing analysis | CAPS1 editing efficiency | Linking RNA editing to DCV exocytosis |
| Immunostaining | Protein localization | Validating DCV protein localization |
| Western blot | Protein expression levels | Confirming knockout or overexpression |
| Calcium imaging | Intracellular calcium dynamics | Correlating calcium signals with exocytosis |
Live-Cell Imaging
Live-cell imaging with fluorescently tagged DCV cargo (e.g., neuropeptide Y-GFP) allows real-time visualization of vesicle trafficking, docking, and fusion events. This method is crucial for understanding the spatiotemporal dynamics of DCV exocytosis.
Electrophysiology
Patch-clamp recordings can measure calcium currents and membrane capacitance changes associated with DCV exocytosis, providing quantitative insights into fusion events.
Proteomics
Mass spectrometry-based proteomics identifies DCV cargo and associated proteins, revealing composition changes in response to genetic manipulations.
Genetic Screens
CRISPR-based screens in neurons or model organisms (e.g., C. elegans) can identify novel regulators of DCV exocytosis.
How CRISPR Can Be Used to Study GO:0099011 neuronal dense core vesicle exocytosis
Knockout
CRISPR knockout of genes such as CAPS1, Munc18-1, or chromogranins in neuronal cell lines or primary neurons can abolish or impair DCV exocytosis, providing causal evidence for their roles. Knockout models are essential for dissecting the molecular machinery of DCV exocytosis.
Point Mutation
Introducing point mutations (e.g., in STXBP1) via CRISPR knock-in allows researchers to study the effects of specific disease-associated variants on DCV exocytosis without confounding effects of complete gene loss. This approach is valuable for modeling neurodevelopmental disorders.
Knock-in
Tagged knock-in of DCV cargo proteins (e.g., NPY-GFP) enables real-time imaging of vesicle dynamics in live neurons. Knock-in of RNA editing sites in CAPS1 can reveal how editing modulates exocytosis.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of genes like NPY can enhance DCV exocytosis, allowing gain-of-function studies. Overexpression models help identify rate-limiting components of the secretory pathway.
How EDITGENE Supports neuronal dense core vesicle exocytosis Research
Researchers studying neuronal dense core vesicle exocytosis-related genes often need to determine whether a candidate gene is causally involved in DCV secretion, how mutations affect protein function, and whether targeting the gene can modulate disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate these investigations.
Contact EDITGENE today to design your custom CRISPR model for neuronal dense core vesicle exocytosis research.
Frequently Asked Questions About neuronal dense core vesicle exocytosis
What is neuronal dense core vesicle exocytosis?
It is the calcium-dependent secretion of neuropeptides and neuromodulators from neuronal dense core vesicles by fusion with the plasma membrane.
What genes are involved in neuronal dense core vesicle exocytosis?
Key genes include CAPS1, UNC-31, Munc18-1, chromogranins A and B, Vti proteins, and neuropeptide Y.
How is neuronal dense core vesicle exocytosis regulated?
It is regulated by calcium influx, CAPS1 RNA editing, neuropeptide Y feedback, and proteins like tomosyn that affect cargo composition.
What is the difference between dense core vesicle and synaptic vesicle exocytosis?
DCV exocytosis releases neuropeptides and neuromodulators slowly and extrasynaptically, while synaptic vesicle exocytosis mediates fast neurotransmission; they use distinct molecular machinery.
Which diseases are linked to defective dense core vesicle exocytosis?
Neurodegenerative diseases, chronic pain, metabolic disorders, and neurodevelopmental disorders such as STXBP1 encephalopathy.
What methods are used to study neuronal dense core vesicle exocytosis?
Live-cell imaging, electrophysiology, proteomics, and CRISPR screens are commonly used.
What is the role of CAPS1 in dense core vesicle exocytosis?
CAPS1 is a calcium-dependent activator essential for DCV exocytosis, and its RNA editing modulates efficiency.
How does Munc18-1 function in dense core vesicle exocytosis?
Munc18-1 promotes DCV docking to the plasma membrane, and its loss impairs secretion.
Can CRISPR be used to study dense core vesicle exocytosis?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise dissection of gene function in DCV exocytosis.
What are dense core vesicles made of?
They contain neuropeptides, neuromodulators, and proteins such as chromogranins, which are essential for their biogenesis.
Conclusion
Neuronal dense core vesicle exocytosis (GO:0099011) is a specialized secretory process critical for neuronal communication and homeostasis. Its molecular machinery, including CAPS1, Munc18-1, and chromogranins, is distinct from that of synaptic vesicle exocytosis and is subject to complex regulation. Dysregulation of DCV exocytosis contributes to neurological and metabolic diseases, making it a promising therapeutic target. Advances in CRISPR-based models and imaging technologies continue to unravel the mechanisms and regulatory networks controlling this process. EDITGENE offers comprehensive services to support research into DCV exocytosis and related diseases.
References
- 1. Subkhangulova A et al.. 2023. Tomosyn affects dense core vesicle composition but not exocytosis in mammalian neurons.. Elife 12 PMID: 37695731
- 2. Dominguez N et al.. 2018. Dense-core vesicle biogenesis and exocytosis in neurons lacking chromogranins A and B.. J Neurochem 144(3):241-254 PMID: 29178418
- 3. Burgoyne RD et al.. 2003. Secretory granule exocytosis.. Physiol Rev 83(2):581-632 PMID: 12663867
- 4. Miyake K et al.. 2016. CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis.. Cell Rep 17(8):2004-2014 PMID: 27851964
- 5. Bost A et al.. 2017. Large dense-core vesicle exocytosis from mouse dorsal root ganglion neurons is regulated by neuropeptide Y.. Neuroscience 346:1-13 PMID: 28089870
- 6. Emperador-Melero J et al.. 2019. Vti Proteins: Beyond Endolysosomal Trafficking.. Neuroscience 420:32-40 PMID: 30471354
- 7. Speese S et al.. 2007. UNC-31 (CAPS) is required for dense-core vesicle but not synaptic vesicle exocytosis in Caenorhabditis elegans.. J Neurosci 27(23):6150-62 PMID: 17553987
- 8. Voets T et al.. 2001. Munc18-1 promotes large dense-core vesicle docking.. Neuron 31(4):581-91 PMID: 11545717
